HIRSCHMAN ORIN 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 4:05 pm Purchase |
2024-12-31 | 13G | scPharmaceuticals Inc. SCPH |
HIRSCHMAN ORIN | 4,200,577 8.400% |
1,093,782 (+35.21%) |
Filing |
| 2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | scPharmaceuticals Inc. SCPH |
HIRSCHMAN ORIN | 3,106,795 8.700% |
556,561 (+21.82%) |
Filing |
| 2023-02-15 06:39 am Unchanged |
2022-12-31 | 13G | scPharmaceuticals Inc. SCPH |
HIRSCHMAN ORIN | 2,550,234 7.500% |
0 (Unchanged) |
Filing |
| 2022-11-25 06:04 am Purchase |
2022-11-22 | 13G | scPharmaceuticals Inc. SCPH |
HIRSCHMAN ORIN | 2,550,234 7.500% |
2,550,234 (New Position) |
Filing |